CAS: 38771-21-0; 4-Bromo-1-Butyne

该化合物是一种有机化合物,其特征是其反白功能组,特别是因丁链中第一和第二碳原子之间存在三重结合而形成的一个终端 .在第四个碳位置上存在溴原子有助于其反应,使其成为有机合成的有用中间体.该化合物一般是无色的,可粉黄的液体,有独特的气味.在水中相对溶解,但易溶于诸如乙醇和乙醇等有机溶剂.4-Bromo-1-butyne可以参与各种化学反应,包括核生殖器替代和混合反应,使其在更复杂的有机分子合成中具有价值.在处理该化合物时,应采取安全防范措施,因为如果皮肤被吸入或吸收,可能会有害.建议将它适当储存在远离光的冷干地方,以便保持其稳定性.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号927-74-2 3-丁炔-1-醇 | CAS号23418-85-1 对甲苯磺酸3-丁炔酯 | CAS号10575-06-1 but-3-ynylsulfa... | CAS号51049-14-0 6,8-二甲氧基-4-甲基喹啉水合物 | CAS号5162-44-7 4-溴-1-丁烯 | CAS号19596-07-7 4-氰基-1-丁炔 | CAS号92144-00-8 1-iodo-2-methyl... | CAS号942518-21-0 N-芴甲氧羰基-L-炔丙基丙氨酸 | CAS号43001-25-8 4-碘-1-丁炔

合成工艺路线路线简述

  • 合成目标产物 4-Bromo-1-Butyne 主要起始原料 3-Butyn-1-Ol
  • (文献来源)合成步骤主要原料 3-Butyn-1-Ol
3-丁炔-1-醇置于phosphorus Tribromide体系中,用27%的收率获得产物4-溴-1-丁炔
参考文献: Hybrid Necroptosis Inhibitors[fr] Inhibiteurs Hybrides De La Nécroptose
标题: Hybrid Necroptosis Inhibitors[fr] Inhibiteurs Hybrides De La Nécroptose
摘要:本发明涉及杂环化合物(例如,由式(i)描述的化合物)及其药学上可接受的盐.该发明还涉及包括这些化合物的药物组合物,以及它们在治疗可能出现大量坏死相关凋亡的疾病中的用途.本文描述的杂环化合物还可以实现对rip1和/或rip3的改进活性和选择性.

海关参考信息

专利信息


专利号:US-6603070-B2
优先权日:2000-07-21
标题 :Convergent synthesis of multiporphyrin light-harvesting rods
发明人:LINDSEY JONATHAN S; LOEWE ROBERT S
权利人:UNIV NORTH CAROLINA STATE
摘要:The present invention provides a convergent method for the synthesis of light harvesting rods. The rods are oligomers of the formula A 1 (A b+1 ) b , wherein b is at least 1, A 1 through A b+1 are covalently coupled rod segments, and each rod segment A 1 through A 1+b comprises a compound of the formula X 1 (X m+1 ) m wherein m is at least 1 and X 1 through X m+1 are covalently coupled porphyrinic macrocycles. Light harvesting arrays and solar cells containing such light harvesting rods are also described, along with intermediates useful in such methods and rods produced by such methods.

专利号:US-9879043-B1
优先权日:2013-06-06
标 题:Synthesis of non-natural cofactor analogs of S-adenosyl-L-methionine using methionine adenosyltransferase
发明人:THORSON JON; HUBER TYLER; ZHANG JIANJUN; Singh Shanteri
权利人:UNIV KENTUCKY RES FOUND
摘要:The present disclosure relates to the synthesis of non-natural analogs of S-adenosyl-L-methionine (SAM) and/or of Se-adenosyl-L-methionine (SeAM) by reacting a methionine analog and adenosine triphosphate (ATP) in the presence of at least one methionine adenosyltransferase (MAT), and to use thereof with downstream SAM and/or SeAM utilizing enzymes. The non-natural analogs of SAM and/or SeAM have the general formula: n nwhere X is S or Se, and R 1 is an alkyl group.

专利号:WO-2024186075-A1
优先权日:2023-03-03
标题 :Synthesis method of antibody-drug conjugates using proximity effect-based site-selective antibody labeling
发明人:LEE HYUN SOO; KIM SOOIN; KWEON YONGSEOK
权利人:UNIV SOGANG RES & BUSINESS DEVELOPMENT FOUND; RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIV
摘要:The present invention relates to a method for the synthesis of an antibody-drug conjugate using proximity effect-based site-selective antibody labeling. Provided according to the present invention may be a method for the synthesis of an antibody-drug conjugate by site-selectively introducing a drug into an antibody using a pyridinium oxime derivative (labeling mediator protein) introduced into a binding protein containing a non-standard amino acid.

专利号:US-10047065-B2
优先权日:2014-12-17
标 题 :Formation of chromanes based on intermolecular reaction of alkynes with dimethylfuran in the presence of gold(I) complexes
发明人:LETINOIS ULLA; NETSCHER THOMAS
权利人:DSM IP ASSETS BV
摘要:The present invention relates to a method of preparing chromanes from 2,5-dimethylfuran and substituted alkynes comprising an long chain unsaturated alkyl group as substituent in the alpha position of a substituted phenol followed by oxidation, reduction and acid ring closure. It is particularly advantageous to use 2,5-dimethylfuran as this offers an ecological beneficial synthesis of β-tocopherol.

专利号:WO-2023092715-A1
优先权日:2021-11-23
标 题:Alanine aggregation-induced emission fluorescent probe, and synthesis method therefor and use thereof
发明人:ZHANG PENGFEI; CHEN GUANGRUI; Xiang Chunbai; LUO YUAN; CAI LINTAO
权利人:SHENZHEN INST ADV TECH
摘要:Provided are an alanine aggregation-induced emission fluorescent probe (TPAPy-D-Ala) having a structure as represented by formula (I), and a synthesis method therefor and the use thereof. The synthesis method for TPAPy-D-Ala comprises: firstly, synthesizing a first compound (TPAPy) as represented by formula (II); synthesizing a second compound (TPAPy-Butyne) as represented by formula (III) on the basis of the first compound; and finally, obtaining the TPAPy-D-Ala as represented by formula (I) on the basis of the second compound. A strategy for directly labeling a target with a fluorophore-D-amino acid is provided, wherein an amino acid is directly coupled with a fluorescent molecule, and participation in the metabolism of the target can be realized via the amino acid. Compared with bio-orthogonal labeling, this strategy can shun two-step operation and a complex catalyst required for a reaction, and achieve one-step direct labeling of a target.

专利号:US-9115172-B2
优先权日:2007-01-11
标 题 :Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
发明人:D SOUZA CHRISTOPHER A; MCBRIDE WILLIAM J; GOLDENBERG DAVID M
权利人:IMMUNOMEDICS INC
摘要:The present application discloses compositions and methods of synthesis and use of 18 F- or 19 F-labeled molecules of use in PET, SPECT and/or MR imaging. Preferably, the 18 F or 19 F is conjugated to a targeting molecule by formation of a complex with a group IIIA metal and binding of the complex to a bifunctional chelating agent, which may then be directly or indirectly attached to the targeting molecule. In other embodiments, the 18 F or 19 F labeled moiety may comprise a targetable construct used in combination with a bispecific antibody to target a disease-associated antigen. The disclosed methods and compositions allow the simple and reproducible labeling of molecules at very high efficiency and specific activity in 30 minutes or less. In preferred embodiments, the bifunctional chelating agent bound to 18 F- or 19 F-metal complex may be conjugated to the molecule to be labeled at a reduced temperature, e.g. room temperature.
安徽济达化工科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jidapharm.com
电话: 0556-5881618 18956990316👤
📞安徽济达化工科技有限公司 ⚠️参考联系方式

销售电话:0556-5881618 18956990316
邮箱:sales@jidapharm.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

安徽省六安经济开发区纬一路中科智能创业园2号楼2层西侧
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
湖南华腾制药有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.huatengsci.com
电话: 400-8592883 15367835770👤
📞湖南华腾制药有限公司 ⚠️参考联系方式

销售电话:400-8592883 15367835770
邮箱:sales@huatengsci.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
上海有德化工科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.udchem.com
企业联系电话:021-37910092👤
📞上海有德化工科技有限公司 ⚠️参考联系方式
联系人:刘先生
电话:021-37910092
手机:15821801668
传真:021-37910267
邮箱:cong44@126.com
通信地址: 上海市金山区蒋庄路2068弄6号楼5楼
邮编: 200137
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:上海市金山区蒋庄路2068弄6号楼5楼
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
海门瑞一医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: https://cn.ruiyitech.com/
电话:021-54718086👤
📞 海门瑞一医药科技有限公司⚠️参考联系方式

电话: 021-54718086
邮件:sales@ruiyitech.com
网址: https://cn.ruiyitech.com/
地址:江苏海门大庆路19号
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

江苏海门大庆路19号
⚠️ 未注册 · 未认证企业
注册入口 备注: 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别. 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1007/s11010-011-0962-7
摘要:Świder R, Masłyk M, Martín-Santamaría S, Ramos A, de Pascual-Teresa B. Multisite-directed inhibitors of protein kinase CK2: new challenges. Molecular and Cellular Biochemistry. 2011 Jul 13;356(1-2):117. doi: 10.1007/s11010-011-0962-7.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知